HOXC8 Suppresses Pyroptosis in NSCLC by Downregulating Caspa
2026-07-03
The referenced study uncovers a novel role for HOXC8 as a suppressor of pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 transcription. These findings highlight the dualistic nature of HOXC8 in cancer biology and suggest new mechanistic links between epigenetic regulation and inflammatory cell death in tumorigenesis.
Pyridostatin TFA: Unlocking G-Quadruplexes in Translational
2026-07-03
Explore how Pyridostatin TFA is transforming G-quadruplex research, bridging cancer and neurodegeneration, and shaping new strategies for translational scientists. This article fuses mechanistic insight, protocol guidance, and strategic foresight, with a special focus on TDP-43 aggregation and telomere biology.
Targeting the CaN/FoxO1/FABP4 Axis in SERCA2 Dysfunction and
2026-07-02
This study identifies the calcineurin/FoxO1/FABP4 signaling pathway as a critical driver of foam cell formation and accelerated atherosclerosis in the context of SERCA2 dysfunction. By demonstrating that pharmacological or genetic inhibition of FABP4 corrects aberrant lipid metabolism, the research highlights a promising mechanistic target for atherosclerosis intervention.
Cabazitaxel (XRP6258): Technical Guidance for Resistant Mode
2026-07-02
Cabazitaxel (XRP6258) addresses taxane resistance in cancer research, specifically in P-glycoprotein-expressing cell lines and taxane-resistant tumor models. It is unsuitable for water-based systems or long-term solution storage, and works best in DMSO- or ethanol-based experimental protocols.
SmD2 Acetylation Modulates PARP Inhibitor Sensitivity in HCC
2026-07-01
This study uncovers how acetylation-dependent regulation of the core spliceosome component SmD2 affects exon usage in hepatocellular carcinoma (HCC) and sensitizes tumors to PARP inhibitors. The findings highlight the therapeutic potential of targeting spliceosome acetylation and combining HDAC inhibition with PARP inhibition in HCC, expanding the rationale for DNA repair deficiency targeting beyond BRCA-mutant cancers.
Applied Cancer Research with Pazopanib (GW-786034): Protocol
2026-07-01
Pazopanib (GW-786034) redefines precision in cancer research by enabling robust multi-targeted inhibition of angiogenic and growth pathways. Discover actionable protocols, troubleshooting tips, and how recent studies in ATRX-deficient glioma models translate into optimized experimental workflows.
TCEP Hydrochloride: Precision Redox Control for Translationa
2026-06-30
Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining the boundaries of translational protein science. This article unpacks its mechanistic roles, strategic integration into advanced workflows—from protein digestion enhancement to next-generation diagnostic assays—and positions it as a keystone for sensitivity-enhanced lateral flow systems. By bridging evidence from recent ‘capture-and-release’ innovations and APExBIO’s product leadership, we provide actionable guidance for researchers aiming to achieve redox precision and translational impact.
Trolox: Antioxidant Mechanisms and Organoid Workflow Integra
2026-06-30
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) is a cell-permeable vitamin E analogue with potent antioxidant activity. It is central to oxidative injury research and high-throughput antioxidant screening, enabling robust modeling and assay standardization. Recent advances highlight its role in efficient pancreatic organoid generation and translational applications.
Heparin Sodium: Applied Workflows in Thrombosis and Exosome
2026-06-29
Heparin sodium from APExBIO enables precision anticoagulation in thrombosis models and advanced workflows, including nanoparticle delivery and exosome interaction studies. This article details protocol enhancements, troubleshooting strategies, and translational insights, linking bench research to practical assay optimization.
CAF-Induced Mitochondrial Rewiring Drives Chemoresistance in
2026-06-29
This study reveals that cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer by secreting ANGPTL4, which activates the IQGAP1-Raf-MEK-ERK-PGC1α axis, enhancing mitochondrial biogenesis and oxidative phosphorylation. The findings identify actionable therapeutic targets and underscore the significance of preserving native protein interactions for robust mechanistic interrogation.
MLN2238 in Proteotoxic Stress and Protein Aggregation Diseas
2026-06-28
Explore MLN2238, a potent proteasome β5 subunit inhibitor, as a tool to dissect proteotoxic stress signaling and protein aggregation pathologies. This article uniquely connects redox-driven CREB/CRTC activation to practical assay design in neurodegenerative and oncology research.
Naloxone Hydrochloride: Advancing Translational Opioid Resea
2026-06-27
This thought-leadership article explores naloxone hydrochloride’s multi-dimensional utility as an opioid receptor antagonist, providing mechanistic and strategic insight for translational researchers. We link receptor signaling, neural stem cell proliferation, and behavioral paradigms, while referencing recent findings on opioid withdrawal and anxiety. The article differentiates itself by integrating advanced protocol guidance and cross-domain conceptual frameworks, positioning APExBIO’s high-purity naloxone as a cornerstone for innovative neurobiological research.
Anagliptin (SK-0403): Applied Workflows in Vascular and Diab
2026-06-26
Anagliptin (SK-0403) uniquely enables simultaneous investigation of DPP-4 inhibition and direct vasorelaxant mechanisms, supporting advanced metabolic and cardiovascular assay designs. This guide delivers actionable workflow enhancements, protocol parameters, and troubleshooting strategies grounded in recent experimental breakthroughs.
BCECF-AM: Ratiometric Intracellular pH Probe for Live Cells
2026-06-26
BCECF-AM is a validated, cell-permeable fluorescent probe for precise intracellular pH measurement in live mammalian, plant, and microbial cells. Its ratiometric emission at 535 nm enables quantitative, reproducible assays, as extensively benchmarked in both primary research and APExBIO documentation. This article synthesizes current best practices, evidence, and technical limits for reliable application.
Cyclo (-RGDfC) in Tumor Targeting: Protocols, Pitfalls, Prog
2026-06-25
Cyclo (-RGDfC), a cyclic RGD peptide, empowers precise αvβ3 integrin targeting in cancer and angiogenesis research, unlocking reproducible cell adhesion, migration, and drug delivery workflows. This article provides actionable protocol enhancements, troubleshooting insights, and bridges findings from osteosarcoma cell viability studies to practical laboratory applications.
459 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page